Zografos L, Mantel I, Schalenbourg A
University Eye Clinic of Lausanne, Jules Gonin Eye Hospital, Lausanne, Switzerland.
Eur J Ophthalmol. 2004 Mar-Apr;14(2):123-31. doi: 10.1177/112067210401400207.
Evaluation of a large series of choroidal nevi inducing the formation of a neovascular membrane in order to more clearly define the clinical presentation and to evaluate the efficacy of various treatment options.
Retrospective study of 22 clinical cases.
All nevi were situated in the posterior choroid. They had a mean diameter of 3.8 mm and a mean thickness of 1.4 mm. Neovascular membranes were classic in all cases, extrafoveal in 13 cases (59%), and subfoveal in 9 cases (41%). A serous retinal detachment was present in every case, hemorrhages were present in 13 cases (59%), and lipid deposits were present in 16 cases (73%). All extrafoveal neovascular membranes were successfully treated by thermal laser photocoagulation. Initial visual acuity was 0.1 in three cases, 0.2-0.4 in five cases, 0.5-0.8 in four cases, and 1.0 or more in two cases. Final visual acuity was 0.1 in one case, 0.2-0.4 in one case, 0.5-0.8 in four cases, and 1.0 or more in seven cases. Five subfoveal neovascular membranes were treated either by thermal laser, photodynamic therapy, or irradiation. No treatment was applied in four cases and in one of these cases, spontaneous resolution of the neovascular membrane was observed. No growth of the pigmented tumor was observed with a mean follow-up of 4.8 years.
Proliferation of a neovascular membrane on the surface of a pigmented choroidal tumor is a rare complication and is considered to be a relative indicator of a benign nature of the lesion. In the authors' experience, neovascular membranes are extrafoveal in more than half of cases and are accessible to laser photocoagulation. In contrast, the various modalities used to treat subfoveal neovascular membrane were ineffective and functional prognosis was unfavorable in these cases.
评估大量诱发新生血管膜形成的脉络膜痣,以便更清晰地界定临床表现并评估各种治疗方案的疗效。
对22例临床病例进行回顾性研究。
所有脉络膜痣均位于脉络膜后部。它们的平均直径为3.8毫米,平均厚度为1.4毫米。所有病例中的新生血管膜均为典型表现,13例(59%)位于黄斑中心凹外,9例(41%)位于黄斑中心凹下。所有病例均存在浆液性视网膜脱离,13例(59%)有出血,16例(73%)有脂质沉着。所有黄斑中心凹外的新生血管膜均通过激光光凝成功治疗。初始视力,3例为0.1,5例为0.2 - 0.4,4例为0.5 - 0.8,2例为1.0或更高。最终视力,1例为0.1,1例为0.2 - 0.4,4例为0.5 - 0.8,7例为1.0或更高。5例黄斑中心凹下的新生血管膜采用激光光凝、光动力疗法或放射治疗。4例未进行治疗,其中1例观察到新生血管膜自发消退。平均随访4.8年,未观察到色素性肿瘤生长。
色素性脉络膜肿瘤表面新生血管膜的增殖是一种罕见并发症,被认为是病变良性性质的相对指标。根据作者的经验,超过半数病例的新生血管膜位于黄斑中心凹外,可进行激光光凝治疗。相比之下,用于治疗黄斑中心凹下新生血管膜的各种方法均无效,这些病例的功能预后不佳。